Genzyme Corporation FDA Record
- Latest inspection VAI · Apr 9, 2026
- Last warning letter 2025
Genzyme Corporation has 6 FDA recalls, 27 inspections, 33 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Genzyme Corporation, the most recent on Jan 15, 2025. FDA has published 5 Form 483s for Genzyme Corporation.
- Latest recall
- D-0362-2025 · Mar 26, 2025 · filed under Chattem
- Latest recall under this name
- D-0075-2018 · Class III · Oct 12, 2017
- Latest inspection
- Apr 9, 2026 · VAI
- Latest 510(k)
- Dec 21, 2010
Newer recall under related name Chattem: Mar 26, 2025, D-0362-2025.
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 6 | Drug: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Device: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Food: Nov 22, 2026 | Drug: File dated Nov 19, 2026; Device: File dated Nov 19, 2026; Food: File dated Nov 19, 2026 | Current |
| 510(k) clearances | 33 | Nov 22, 2026 | File dated Nov 18, 2026 | Current |
| Inspections | 27 | Nov 22, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 1 | Nov 22, 2026 | Newest record Nov 13, 2026 | Current |
FDA record by year
Genzyme Corporation: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 1 | 0 | 0 | 0 | 0 |
| 2025 | 2 | 0 | 1 | 0 | 0 |
| 2024 | 1 | 1 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 1 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 1 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 1 | 0 | 0 | 0 | 0 |
| 2017 | 1 | 0 | 0 | 1 | 0 |
Reviewing Genzyme Corporation as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Genzyme Corporation yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Genzyme Corporation FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| Jan 15, 2025 · Record page |
Genzyme Corporation Form 483s
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0075-2018 | Class III | Clolar (clofarabine) 20 mg/20 mL (1 mg/mL) Injection, for intravenous use, Rx Only, Mfd. by: Teva… | Oct 12, 2017 |
| D-0729-2016 | Class II | Thyrogen (thyrotropin alfa for injection), 0.9 mg/mL after reconstitution, For intramuscular… | Feb 16, 2016 |
| D-0730-2016 | Class II | Thyrogen (thyrotropin alfa for injection), 0.9 mg/mL after reconstitution, For intramuscular… | Feb 16, 2016 |
| D-0799-2016 | Class III | Lumizyme (alglucosidase alpha), 50 mg/vial, For Intravenous Infusion Only, Rx Only, Manufactured by… | Dec 8, 2015 |
| Z-1856-2012 | Class II | seprafilm¿ Single Site ADHESION BARRIER Re-order Number: 6641-01 Product Usage: Seprafilm… | Jun 13, 2012 |
| Z-1855-2012 | Class II | seprafilm¿ Procedure Pack ADHESION BARRIER Re-order Number: 5086-02 Product Usage: Seprafilm… | Jun 13, 2012 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Apr 9, 2026 | Framingham, MA | Drugs | Voluntary Action Indicated (VAI) | 1220423 |
| Aug 14, 2025 | Northborough, MA | Drugs | No Action Indicated (NAI) | 3009389940 |
| Feb 14, 2025 | Northborough, MA | Biologics | Voluntary Action Indicated (VAI) | 3009389940 |
| Jul 9, 2024 | Framingham, MA | Drugs | Official Action Indicated (OAI) | 1220423 |
| Jul 25, 2022 | Framingham, MA | Drugs | Voluntary Action Indicated (VAI) | 1220423 |
| Feb 28, 2020 | Northborough, MA | Drugs | No Action Indicated (NAI) | 3009389940 |
| Jul 19, 2018 | Northborough, MA | Drugs | No Action Indicated (NAI) | 3009389940 |
| Feb 2, 2017 | Framingham, MA | Drugs | No Action Indicated (NAI) | 1220423 |
| Aug 18, 2016 | Northborough, MA | Drugs | Voluntary Action Indicated (VAI) | 3009389940 |
| Aug 10, 2016 | Cambridge, MA | Drugs | No Action Indicated (NAI) | 1221955 |
| Nov 21, 2014 | Framingham, MA | Drugs | Voluntary Action Indicated (VAI) | 1220423 |
| Sep 25, 2014 | Framingham, MA | Drugs | Voluntary Action Indicated (VAI) | 1220423 |
| Sep 18, 2014 | Northborough, MA | Drugs | No Action Indicated (NAI) | 3009389940 |
| Aug 22, 2014 | Cambridge, MA | Drugs | No Action Indicated (NAI) | 1221955 |
| Mar 25, 2014 | Cambridge, MA | Drugs | No Action Indicated (NAI) | 1221955 |
| Sep 30, 2013 | Cambridge, MA | Drugs | Voluntary Action Indicated (VAI) | 1221955 |
| Apr 9, 2013 | Northborough, MA | Devices | No Action Indicated (NAI) | 3009389940 |
| Oct 5, 2012 | Cambridge, MA | Drugs | No Action Indicated (NAI) | 1221955 |
| Jul 13, 2012 | Framingham, MA | Drugs | Voluntary Action Indicated (VAI) | 1220423 |
| Feb 17, 2012 | Northborough, MA | Drugs | No Action Indicated (NAI) | 3009389940 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 1 compliance action under Genzyme Corporation: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 1220423 | Framingham, MA | 9 | Apr 9, 2026 |
| FEI 3009389940 | Northborough, MA | 8 | Aug 14, 2025 |
| FEI 1221955 | Cambridge, MA | 9 | Aug 10, 2016 |
| FEI 3003984125 | Oxford, United Kingdom | 1 | Aug 6, 2009 |
Recent 510(k) clearances
| K-Number | Device | Date |
|---|---|---|
| K102242 | OSOM C. DIFFICILE TOXIN A/B TEST | Dec 21, 2010 |
| K092633 | OSOM INFLUENZA A&B TEST , MODEL PN190 | Sep 25, 2009 |
| K080662 | GENZYME CYSTATIN C REAGENT ANF GENZYME CYSTATIN C CALIBRATOR | May 15, 2008 |
| K063739 | SEPRAMESH, MODEL 5959-1214 | Jan 17, 2007 |
| K061508 | OSOM INFLUENZA A&B TEST | Jun 12, 2006 |
| K051244 | GENZYME OSOM INFLUENZA A & B TEST | Feb 21, 2006 |
| K053066 | SEPRAMESH IP BIORESORBABLE COATING/PERMANENT MESH | Dec 19, 2005 |
| K043035 | SEPRAGEL ENT BIORESORBABLE PACKING/STENT | Jul 11, 2005 |
| K040241 | N-GENEOUS WIDE RANGE CRP REAGENT AND CALIBRATOR SET | Jun 25, 2004 |
| K040868 | SEPRAMESH IP BIORESORBABLE BARRIER - PERMANENT MESH | Jun 4, 2004 |
| K033864 | GENZYME OSOM TRICHOMONAS RAPID TEST | Apr 2, 2004 |
| K023544 | GENZYME CONTRAST II HCG URINE/SERUM TEST | Jan 16, 2003 |
| K021316 | ULTRA N-GENEOUS HDL CHOLESTEROL REAGENT 1/REAGENT2; ULTRA N-GENEOUS HDL CHOLESTREOL CALIBRATOR | Jul 25, 2002 |
| K021019 | COTTONY II, SILKY II POLYDEK & TEVDEK II POLYESTER SUTURE | Jun 18, 2002 |
| K012532 | SEPRAGEL SINUS | Oct 30, 2001 |
| K011843 | GENZYME DIRECT-AMYLASE TEST REAGENT | Aug 10, 2001 |
| K000239 | GLYPRO REAGENT, GLYPRO CALIBRATOR, GLYPRO LOW CONTROL, GLYPRO HIGH CONTROL | Mar 21, 2000 |
| K994328 | SEPRAMESH BIOSURGICAL COMPOSITE, MODEL SMBC-XXX | Mar 2, 2000 |
| K992766 | N-GENEOUS LDL-ST CHOLESTEROL REAGENT, N-GENEOUS LDL-ST CHOLESTEROL CALIBRATOR, GENZYME LDL… | Oct 18, 1999 |
| K993132 | GENZYME DIRECT AMYLASE VERIFIER | Oct 4, 1999 |
Genzyme Corporation and the FDA: common questions
Has Genzyme Corporation received an FDA warning letter?
Yes. FDA has issued 1 warning letter to Genzyme Corporation. The most recent is dated Jan 15, 2025.
Has Genzyme Corporation received an FDA Form 483?
FDA has published 5 Form 483s for Genzyme Corporation in its reading room, the most recent dated Apr 9, 2026. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Genzyme Corporation?
The most recent FDA inspection on file ended Apr 9, 2026 at Framingham, MA and was classified VAI. FDA has 27 inspections of Genzyme Corporation on file, 2 of them classified OAI (official action indicated).
Has Genzyme Corporation had an FDA recall?
Yes. Genzyme Corporation has 6 FDA recalls on record. The most recent under this name started Oct 12, 2017. A newer recall, dated Mar 26, 2025, is filed under the related name Chattem.
Need more than this page shows? Ask about Genzyme Corporation in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.